Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia

被引:55
|
作者
Bhatia, S [1 ]
机构
[1] City Hosp Canc Ctr, Div Pediat, Duarte, CA 91010 USA
关键词
acute lymphoblastic leukemia; risk factors; race ethnicity; socioeconomic status;
D O I
10.1097/00008480-200402000-00004
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose of review Overall, childhood acute lymphoblastic leukemia is associated with an excellent outcome. The improvement in survival achieved during the last three decades is partially attributed to the identification of risk factors predicting a poor outcome and risk-stratified treatment of patients placed on well-designed therapeutic trials. Accordingly, it is important to continue to identify patient subgroups with differences in outcome to focus efforts to improve overall survival. Black children historically have been reported to have a poorer survival rate compared with whites, but limited information is available for children from other racial/ethnic backgrounds. Recent findings Several groups have published reports on ethnic and racial differences in survival after childhood acute lymphoblastic leukemia, with poorer outcomes reported for black children compared with whites reported by the majority of the studies. Limited information is available for children from other racial/ethnic backgrounds, such as Hispanics and Asians, but data indicate that Hispanics have poorer survival than whites, whereas Asians from the United States have outcomes that are as good or better than those of the whites, especially among the high-risk group treated with contemporary risk-based therapy. The influence of race and ethnicity on survival should be closely linked with socioeconomic status. However, few studies have specifically investigated the influence of nutrition and socioeconomic factors on the prognosis of children with acute lymphoblastic leukemia, and the results are conflicting. Summary Future studies need to focus on the reasons for these differences, including racial and ethnic differences in adherence with therapeutic protocols, and ethnic differences in drug metabolism and bioavailability of the agents commonly used in acute lymphoblastic leukemia, so that drug administration can be modified if needed.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [21] Outcome of Childhood Acute Lymphoblastic Leukemia With Induction Failure Treated by the Japan Association of Childhood Leukemia Study (JACLS) ALL F-Protocol
    Suzuki, Nobuhiro
    Yumura-Yagi, Keiko
    Yoshida, Makoto
    Hara, Junichi
    Nishimura, Shinichiro
    Kudoh, Tooru
    Tawa, Akio
    Usami, Ikuya
    Tanizawa, Akihiko
    Hori, Hiroki
    Ito, Yasuhiko
    Miyaji, Ryosuke
    Oda, Megumi
    Kato, Koji
    Hamamoto, Kazuko
    Osugi, Yuko
    Hashii, Yoshiko
    Nakahata, Tatsutoshi
    Horibe, Keizo
    PEDIATRIC BLOOD & CANCER, 2010, 54 (01) : 71 - 78
  • [22] Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
    Anna Wojtuszkiewicz
    Godefridus J. Peters
    Nicole L. van Woerden
    Boas Dubbelman
    Gabriele Escherich
    Kjeld Schmiegelow
    Edwin Sonneveld
    Rob Pieters
    Peter M. van de Ven
    Gerrit Jansen
    Yehuda G. Assaraf
    Gertjan J. L. Kaspers
    Jacqueline Cloos
    Journal of Hematology & Oncology, 8
  • [23] Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
    Wojtuszkiewicz, Anna
    Peters, Godefridus J.
    van Woerden, Nicole L.
    Dubbelman, Boas
    Escherich, Gabriele
    Schmiegelow, Kjeld
    Sonneveld, Edwin
    Pieters, Rob
    van de Ven, Peter M.
    Jansen, Gerrit
    Assaraf, Yehuda G.
    Kaspers, Gertjan J. L.
    Cloos, Jacqueline
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [24] Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia
    Velentza, Lilly
    Zaman, Farasat
    Savendahl, Lars
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168
  • [25] Immunologic profile and outcome of childhood acute lymphoblastic leukemia (ALL) in Morocco
    Dakka, Nadia
    Bellaoui, Hicham
    Khattab, Mohammed
    Brahimi-Horn, Marie C.
    Aoued, Leila
    Bouzid, Nadia
    Bakri, Youssef
    Benjouad, Abdelaziz
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (08) : 574 - 580
  • [26] Management of Brain Abscesses in Children Treated for Acute Lymphoblastic Leukemia
    Lackner, Herwig
    Sovinz, Petra
    Benesch, Martin
    Smolle-Juettner, Freyja
    Mokry, Michael
    Schwinger, Wolfgang
    Moser, Andrea
    Urban, Christian
    PEDIATRIC BLOOD & CANCER, 2009, 52 (03) : 408 - 411
  • [27] Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study
    Koh, Kyung-Nam
    Im, Ho Joon
    Kim, Hyery
    Kang, Hyoung Jin
    Park, Kyung Duk
    Shin, Hee Young
    Ahn, Hyo Seop
    Lee, Ji Won
    Yoo, Keon Hee
    Sung, Ki Woong
    Koo, Hong Hoe
    Lim, Young Tak
    Park, Jun Eun
    Park, Byung-Kiu
    Park, Hyeon Jin
    Seo, Jong Jin
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (04) : 642 - 649
  • [28] Outcome of very late relapse in children with acute lymphoblastic leukemia
    Rizzari, C
    Valsecchi, MG
    Aricò, M
    Miniero, R
    Messina, C
    De Rossi, G
    Testi, AM
    Mura, R
    Galimberti, S
    Biondi, A
    Locatelli, F
    Conter, V
    HAEMATOLOGICA, 2004, 89 (04) : 427 - 434
  • [29] Inferior outcomes for black children with high risk acute lymphoblastic leukemia and the impact of socioeconomic variables
    Walsh, Alexandra
    Chewning, Joseph
    Li, Xuelin
    Dai, Chen
    Whelan, Kimberly
    Madan-Swain, Avi
    Waterbor, John
    Baskin, Monica L.
    Goldman, Frederick D.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (02) : 267 - 274
  • [30] Could intensified treatment in childhood acute lymphoblastic leukemia improve outcome independently of risk factors?
    Tzortzatou-Stathopoulou, F
    Moschovi, MA
    Papadopoulou, AL
    Barbounaki, IG
    Lambrou, GI
    Balafouta, M
    Syriopoulou, V
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (05) : 361 - 369